These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 25247665

  • 21. Treatment strategies for hemoglobin E beta-thalassemia.
    Olivieri NF.
    Blood Rev; 2012 Apr; 26 Suppl 1():S28-30. PubMed ID: 22631039
    [Abstract] [Full Text] [Related]

  • 22. Congestive heart failure and treatment in thalassemia major.
    Aessopos A, Kati M, Tsironi M.
    Hemoglobin; 2008 Apr; 32(1-2):63-73. PubMed ID: 18274984
    [Abstract] [Full Text] [Related]

  • 23. An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
    Saeidnia M, Fazeli P, Farzi A, Atefy Nezhad M, Shabani-Borujeni M, Erfani M, Tamaddon G, Karimi M.
    Hemoglobin; 2023 Nov; 47(2):56-70. PubMed ID: 37325871
    [Abstract] [Full Text] [Related]

  • 24. Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.
    Meloni A, Pistoia L, Ricchi P, Bagnato S, Longo F, Messina G, Bagnato S, Rossi V, Renne S, Righi R, Fina P, Positano V, Cademartiri F.
    Ann Hematol; 2024 Jun; 103(6):1887-1896. PubMed ID: 38581547
    [Abstract] [Full Text] [Related]

  • 25. An update on thalassemia intermedia.
    Maakaron JE, Cappellini MD, Taher AT.
    J Med Liban; 2013 Jun; 61(3):175-82. PubMed ID: 24422369
    [Abstract] [Full Text] [Related]

  • 26. Hydroxyurea in the management of thalassemia intermedia.
    Karimi M.
    Hemoglobin; 2009 Jun; 33 Suppl 1():S177-82. PubMed ID: 20001623
    [Abstract] [Full Text] [Related]

  • 27. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
    Rafsanjani KA, Mafi N, Tafreshi RI.
    Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
    [Abstract] [Full Text] [Related]

  • 28. [Clinical management of beta-thalassaemia].
    Thuret I.
    Rev Prat; 2014 Oct; 64(8):1132-7. PubMed ID: 25510144
    [Abstract] [Full Text] [Related]

  • 29. Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.
    Cario H, Wegener M, Debatin KM, Kohne E.
    Ann Hematol; 2002 Aug; 81(8):478-82. PubMed ID: 12224008
    [Abstract] [Full Text] [Related]

  • 30. Cross-talk between available guidelines for the management of patients with beta-thalassemia major.
    Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB.
    Acta Haematol; 2013 Aug; 130(2):64-73. PubMed ID: 23485589
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Alpha and beta thalassemia.
    Muncie HL, Campbell J.
    Am Fam Physician; 2009 Aug 15; 80(4):339-44. PubMed ID: 19678601
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Increasing prevalence of thalassemia in America: Implications for primary care.
    Sayani FA, Kwiatkowski JL.
    Ann Med; 2015 Aug 15; 47(7):592-604. PubMed ID: 26541064
    [Abstract] [Full Text] [Related]

  • 35. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.
    Blood Cells Mol Dis; 2009 Aug 15; 42(3):247-51. PubMed ID: 19233692
    [Abstract] [Full Text] [Related]

  • 36. Severe β-thalassemia intermedia in a compound heterozygous patient for the -30 (T>A) β(+)-thalassemia mutation and the δ(0)β(+)-Senegalese deletion.
    Griffon C, Joly P, Sénéchal A, Philit F, Francina A.
    Hemoglobin; 2010 Aug 15; 34(5):505-8. PubMed ID: 20854126
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Extramedullary hematopoiesis with spinal cord compression in a child with thalassemia intermedia.
    Ileri T, Azik F, Ertem M, Uysal Z, Gozdasoglu S.
    J Pediatr Hematol Oncol; 2009 Sep 15; 31(9):681-3. PubMed ID: 19687759
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E.
    Ann Hematol; 2005 Jun 15; 84(6):353-7. PubMed ID: 15711802
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.